News

Health Rounds: Roche's Tecentriq reduces recurrence, deaths for certain colon cancer patients
Patients in the study had tumors with a genetic defect known as deficient DNA mismatch repair, or dMMR. About 15% of colon ...
Roche’s Tecentriq With Lurbinectedin Increases Survival to Small-Cell Lung Cancer, Study Says
The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in ...
Fierce Biotech5d
Bayer's Vividion secures rights to only clinical-stage covalent WRN inhibitor from partner Roche
Bayer’s Vividion Therapeutics has secured the global rights from its partner Roche to the only Werner helicase (WRN) ...
STAT13d
Pharmalittle: We’re reading about a Roche antibiotic, a gene therapy patient death, and more
Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...
BioSpace6d
Roche and Jazz Link Drug Combo to Improved Survival in Phase III Lung Cancer Trial
Analysts said the data suggest “a strong treatment effect.” Jazz has filed for FDA approval for the combination, which could ...
Roche extends trials of antibiotic against resistant superbug, FT reports
Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...
As a child, Roche heir André Hoffmann ran around in a WWF T-shirt. Today he says: «We can't go on like this»
André Hoffmann, the vice chairman and major shareholder of pharmaceutical giant Roche, sees protecting nature as the only ...
Roche’s Tecentriq With Lurbinectedin Increases Survival From Small-Cell Lung Cancer, Study Says
The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in ...
Wall Street Journal6d
Roche’s Tecentriq With Lurbinectedin Increases Survival From Small-Cell Lung Cancer, Study Says
Roche said Tecentriq combined with lurbinectedin shows significant survival benefits for patients with extensive-stage small cell lung cancer. The Swiss pharmaceutical company said Tuesday that ...